Aptatek HomeCheck System for PKU

About Aptatek BioSciences

Aptatek BioSciences is a private, pre-revenue diagnostics company founded in 2014 and headquartered in Philadelphia. It is developing the Aptatek HomeCheck System, a portable diagnostic platform that uses DNA aptamers to detect small-molecule biomarkers with clinical lab sensitivity, starting with an FDA-designated Breakthrough Device for PKU monitoring. The technology, licensed from Columbia University, aims to decentralize testing for chronic conditions, allowing for immediate dietary or medication adjustments. The company is led by CEO Michael Boyce-Jacino and is supported by a scientific team including the technology's academic founders.

Therapeutic Areas